Cardiac Troponin as a Prognostic Indicator for Major Adverse Cardiac Events in Non-Cardiac Surgery: A Narrative Review
Diagnostics · 22.04.2025 · 15 (9) · 1061
DOI: 10.3390/diagnostics15091061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 22.04.2025. Verfasst von Syarifah Noor Nazihah Sayed Masri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology & Intensive Care, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur 56…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A major adverse cardiac event (MACE) following non-cardiac surgery encompasses critical postoperative cardiovascular complications such as myocardial infarction or injury, cardiac arrest, or stroke that are associated with increased perioperative morbidity, mortality, and healthcare resource utilisation. Cardiac troponin (cTn), particularly high-sensitivity cardiac troponin (hs-cTn), has emerged as a key biomarker for prediction of MACE. Despite its recognised utility, there is no consensus on how cTn levels should be used for standardised postoperative surveillance. Interpretation of the cTn levels may vary depending on sex-specific reference values and baseline comorbidities such as chronic kidney disease, sepsis, critical illness, and non-ischaemic conditions. The balance between cost-effectiveness and clinical benefit in implementing universal versus targeted postoperative hs-cTn screening remains to be fully explored. This review examines the prognostic value of cardiac troponin (cTn) levels in predicting major adverse cardiovascular events (MACEs) in patients undergoing non-cardiac surgery, with a focus on perioperative cTn elevations—particularly those associated with myocardial injury after non-cardiac surgery (MINS)—as potential early indicators of increased cardiovascular risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology & Intensive Care, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
- Department of Anaesthesiology & Intensive Care, Hospital Kuala Lumpur, Kuala Lumpur 50586, Malaysia.
- Department of Anaesthesiology & Intensive Care, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
ORCID-Profile: Syarifah Noor Nazihah Sayed Masri, Fadzwani Basri, Siti Nadzrah Yunus, Saw Kian Cheah
Zitieren
APA
Sayed Masri, S. N. N., Basri, F., Yunus, S. N., & Cheah, S. K. (2025). Cardiac Troponin as a Prognostic Indicator for Major Adverse Cardiac Events in Non-Cardiac Surgery: A Narrative Review. Diagnostics, 15(9), 1061. https://doi.org/10.3390/diagnostics15091061
Vancouver
Sayed Masri SNN, Basri F, Yunus SN, Cheah SK. Cardiac Troponin as a Prognostic Indicator for Major Adverse Cardiac Events in Non-Cardiac Surgery: A Narrative Review. Diagnostics. 2025;15(9):1061. doi:10.3390/diagnostics15091061
BibTeX
@article{SayedMasri2025,
author = {Sayed Masri, Syarifah Noor Nazihah and Basri, Fadzwani and Yunus, Siti Nadzrah and Cheah, Saw Kian},
title = {Cardiac Troponin as a Prognostic Indicator for Major Adverse Cardiac Events in Non-Cardiac Surgery: A Narrative Review},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {9},
pages = {1061},
doi = {10.3390/diagnostics15091061}
}
EUVIMED